Japanese Pharmas Hit By Strong Yen: Japanese Pharma Earnings Roundup
This article was originally published in PharmAsia News
Executive Summary
TOKYO - As expected, top Japanese pharmaceutical players have reported lackluster April-June earnings as they struggled under the strong yen's weight, with three leading firms reiterating efforts to expedite launching products now in the pipelines